Assessing the Time Demands of Cancer

University of Minnesota (UMN)

Status: Active, not recruiting

Conditions: Metastatic Breast Cancer; Ovarian Cancer

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT05708703

2022LS100

1R01CA277714-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry the smartphone for 28 consecutive days while outside the home; keep smartphone location and motion services active; confirm and correct (if needed) smartphone-detected activities and trips; use the app interface to provide additional information on activities and trips related to cancer treatment tasks; complete daily surveys regarding well-being; and at the end of the 28 day period, complete an online survey.

Enrollment: 78 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age or older
• Diagnosed with advanced stage (III, IV) ovarian (ovarian, fallopian tube or primary peritoneal) or metastatic breast cancer [do not need to be newly diagnosed]
• Currently receiving any type of therapy for their cancer [can be front-line, maintenance therapy, or treatment for recurrence]
• Able to complete study tasks in English
• Able to provide voluntary informed consent
• Own an Android or iOS smartphone on which the operating system is version 9.0 or higher for Android or 10.0 higher for iOS; or willing to use a researcher-provided smartphone

Exclusion criteria

• Those who are currently incarcerated
• Have opted out of research contact

Trial design

78 participants in 1 patient group

Study cohort

Description:

Individuals receiving treatment for metastatic breast cancer or advanced stage ovarian cancer, will complete a baseline survey, install a mobile app on their smartphone to track daily activities, short daily surveys, and a study end survey